Patent · US Active

Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5

US9089476B2 · kind B2 · utility

8Cited by
7References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 9, 2012
Grant dateJul 28, 2015
Priority date
Expiry dateAug 9, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition in the form of an injectable aqueous solution, the pH of which is between 6.0 and 8.0, includes at least a basal insulin, the isoelectric point pI of which is between 5.8 and 8.5; and a dextran substituted by radicals carrying carboxylate charges and hydrophobic radicals. Single-dose formulations at a pH of between 7 and 7.8 includes a basal insulin whose isoelectric point is between 5.8 and 8.5 and a prandial insulin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.